-
Teva announces launch of Adasuve
JERUSALEM — Teva Pharmaceutical Industries announced the launch of Adasuve (loxapine) inhalation powder in a 10-mg dosage. The drug is the first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar disorder in adults.
-
Oral-B launches oral care app for children to help increase brushing time
CINCINNATI — Procter & Gamble’s Oral-B has announced the launch of an oral care app for children — the Disney Magic Timer App by Oral-B.
Created in collaboration with Disney and powered by DreamPlay, the oral care app is designed to helps kids increase brushing time, which is identified by dentists as an area of concern and improvement for children.